Regulation of expression of 11β-hydroxysteroid dehydrogenase type 1 in adipose tissue: Tissue-specific induction by cytokines

Endocrinology

Volumn 142, Issue 5, 2001, Pages 1982-1989

  Tomlinson, J W ^a   Moore, J ^a   Cooper, M S ^a   Bujalska, I ^a   Shahmanesh, M ^b   Burt, C ^a   Strain, A ^a   Hewison, M ^a   Stewart, P M ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b SELLY OAK HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; CORTISONE; CYTOKINE; GLUCOCORTICOID; HYDROCORTISONE; INTERLEUKIN 1BETA; LEPTIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SOMATOMEDIN C; TUMOR NECROSIS FACTOR ALPHA; 15 DEOXY DELTA(12,14) PROSTAGLANDIN J2; 15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J2; DRUG DERIVATIVE; HYDROXYSTEROID DEHYDROGENASE; INDINAVIR; INTERLEUKIN 1; ISOENZYME; PROSTAGLANDIN D2;

ADIPOCYTE; ADIPOSE TISSUE; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN TISSUE; LIVER CELL; OBESITY; OMENTUM; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; STROMA CELL; ANTIBODY SPECIFICITY; CYTOLOGY; DRUG EFFECT; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS;

11-BETA-HYDROXYSTEROID DEHYDROGENASES; ADIPOSE TISSUE; CELLS, CULTURED; CYTOKINES; GENE EXPRESSION REGULATION; HUMANS; HYDROXYSTEROID DEHYDROGENASES; INDINAVIR; INSULIN-LIKE GROWTH FACTOR I; INTERLEUKIN-1; ISOENZYMES; LEPTIN; ORGAN SPECIFICITY; PROSTAGLANDIN D2; STROMAL CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 85047681877     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.142.5.8168     Document Type: Article

References (41)

1. Obesity
2. Increasing prevalence of overweight among US adults. The National Health and Nutrition Examination Surveys 1960 to 1991
3. Body fat distribution and coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes mellitus: The Paris Prospective Study, 15-year follow-up
4. Upper-body fat distribution: A hyperinsulinemia-independent predictor of coronary heart disease mortality. The Paris Prospective Study
5. Does central obesity reflect "Cushing's disease of the omentum?"
6. Cortisol metabolism in human obesity: Impaired cortisone→cortisol conversion in subjects with central adiposity
7. Understanding the role of glucocorticoids in obesity: Tissue-specific alterations of corticosterone metabolism in obese Zucker rats
8. Regulation of adipocyte gene expression and differentiation by peroxisome proliferator activated receptor gamma
9. 15-Deoxy-Δ12,14-prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ
10. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation
11. Pseudo-Cushing's syndrome in human immunodeficiency virus-infected patients
12. Indinavir-associated lipodystrophy
13. Differentiation of adipose stromal cells: The roles of glucocorticoids and 11β-hydroxysteroid dehydrogenase
14. Regulation of 11β-hydroxysteroid dehydrogenase type 1 in primary cultures of rat and human hepatocytes
15. Human 11β-hydroxysteroid dehydrogenase: Studies on the stably transfected isoforms and localization of the type 2 isozyme within renal tissue
16. 11β-hydroxysteroid dehydrogenase 1 in adipocytes: Expression is differentiation-dependent and hormonally regulated
17. Cortisol secretion in relation to body fat distribution in obese premenopausal women
18. Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance
19. Tumor necrosis factor α and interleukin 1β enhance the cortisone/cortisol shuttle
20. Insulin attenuates the stimulatory effects of tumor necrosis factor α on 11β-hydroxysteroid dehydrogenase 1 in human adipose stromal cells
21. Tumor necrosis factor-α induces apoptosis of human adipose cells
22. Tumor necrosis factor-α prevents the differentiation of human adipocyte precursor cells and causes delipidation of newly developed fat cells
23. Interferons and tumor necrosis factors have similar catabolic effects on 3T3 L1 cells
24. TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation
25. Targeted disruption of the tumor necrosis factor-α gene: Metabolic consequences in obese and nonobese mice
26. Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss
27. Leptin and the regulation of body weight in mammals
28. Massive weight loss restores 24-hour growth hormone release profiles and serum insulin-like growth factor-1 levels in obese subjects
29. Growth hormone treatment improves serum lipids and lipoproteins in adults with growth hormone deficiency
30. Long-term follow-up of hypopituitary patients treated with human growth hormone
31. Modulation of 11β-hydroxysteroid dehydrogenase isozymes by growth hormone and insulin-like growth factor: In vivo and in vitro studies
32. The effect of growth hormone replacement therapy on cortisol-cortisone interconversion in hypopituitary adults: Evidence for growth hormone modulation of extrarenal 11β-hydroxysteroid dehydrogenase activity
33. Sexual dimorphism of hepatic 11β-hydroxysteroid dehydrogenase in the rat: The role of growth hormone patterns
34. 11β-Hydroxysteroid dehydrogenase is an exclusive 11β-reductase in primary cultures of rat hepatocytes: Effect of physiochemical and hormonal manipulations
35. Effect of growth hormone, insulin and dexamethasone on 11β-hydroxysteroid dehydrogenase activity on a primary culture of rat hepatocytes
36. 15-Deoxy-Δ(12,14) prostaglandin J2: A putative endogenous promoter of adipogenesis suppresses the ob gene
37. Increased soft tissue in the posterior cervical and upper back area of patients on HIV-1 protease inhibitors
38. Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance
39. Recent advances in the molecular basis of TNF signal transduction
40. Characterisation of the proximal promoter region of the human type 1 11β-hydroxysteroid dehydrogenase gene
41. Variation among cell types in the signalling pathways by which IGF-I stimulates specific cellular responses